Pengfei Li
Xi'an, 710069, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
Journal: Glycoconjugate journal
Published: August 01, 2022
De-sialylation of glycopeptides by acid treatment: enhancing sialic acid removal without reducing the identification.
Journal: Analytical methods : advancing methods and applications
Published: July 25, 2022
Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT.
Journal: Theranostics
Published: December 07, 2020
Corrigendum: MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment.
Journal: Frontiers in cell and developmental biology
Published: July 15, 2020
Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib.
Journal: The Analyst
Published: June 10, 2020
Site-Specific N-Glycoproteomic Analysis Reveals Upregulated Sialylation and Core Fucosylation during Transient Regeneration Loss in Neonatal Mouse Hearts.
Journal: Journal of proteome research
Published: May 20, 2020
MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment.
Journal: Frontiers in cell and developmental biology
Published: May 01, 2020
Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations.
Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations.
Journal: Frontiers in oncology
Published: November 30, 2019
PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab.
Journal: Cancer immunology, immunotherapy : CII
Published: July 24, 2019
Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation.
Journal: Biochemical pharmacology
Published: November 10, 2017
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.
Journal: Cell & bioscience
Published: August 11, 2017
Last Updated: 09/26/2026